A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Research Site, Sandvika

Research Site, Glostrup Municipality

Research Site, Lillehammar

Research Site, Stavanger

Research Site, Ålesund

Research Site, Berlin

Research Site, Berlin

Research Site, Amherst

Research Site, Philadelphia

Research Site, Turku

Research Site, Hamburg

Research Site, Pikesville

Research Site, Virginia Beach

Research Site, Kiel

Research Site, Greensboro

Research Site, Decatur

Research Site, Atlanta

Research Site, Jacksonville

Research Site, Orlando

Research Site, Tampere

Research Site, West Palm Beach

Research Site, Palm Beach Gardens

Research Site, Nashville

Research Site, Jyväskylä

Research Site, Cleveland

Research Site, Bochum

Research Site, Essen

Research Site, Indianapolis

Research Site, Ann Arbor

Research Site, Kalamazoo

Research Site, Milwaukee

Research Site, Königstein im Taunus

Research Site, St Louis

Research Site, Springfield

Research Site, Dallas

Research Site, Dallas

Research Site, Temple

Research Site, Austin

Research Site, Reno

Research Site, Oulu

Research Site, Santa Monica

Research Site, Sherman Oaks

Research Site, La Jolla

Research Site, Newport Beach

Research Site, San Francisco

Research Site, Stanford

Research Site, Stamford

Research Site, Watertown

Research Site, Worcester

Research Site, Seattle

Research Site, Calgary

Research Site, Montreal

Research Site, Brno

Research Site, Brno

Research Site, Prague

Research Site, Prague

Research Site, Helsinki

Research Site, Krakow

Research Site, Lodz

Research Site, Lublin

Research Site, Poznan

Research Site, Świdnik

Research Site, Warsaw

Research Site, Warsaw

Research Site, Warsaw

Research Site, Falköping

Research Site, Stockholm

Research Site, Stockholm

Research Site, Stockholm

Research Site, Vällingby

Research Site, Glasgow

Research Site, Hull

Research Site, London

Research Site, Stoke-on-Trent